HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Lupin executes BTA for transfer of API R&D Division to Lupin Manufacturing Solutions
Jul-01-2025

Lupin has executed a Business Transfer Agreement (BTA) for transfer of its API R&D Division situated at Pune, to Lupin Manufacturing Solutions, a wholly owned subsidiary of the Company, on a slump sale basis. In terms of the BTA, the said transaction has been completed and transfer of API R&D Division is effective from July 01, 2025.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

  RELATED NEWS >>